Tofacitinib Impurity 33 | CAS 16372-08-0 - Request Quote
Tofacitinib Impurity 33
| SZ CAT No: | SZ-T010087 |
| CAS No | 16372-08-0 |
| Mol.F. | C6H6ClN3 |
| Mol.Wt. | 155.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tofacitinib Impurity 33 is chemically 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine. Tofacitinib Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 16372-08-0
Purchase 16372-08-0
Order 16372-08-0
Enquire 16372-08-0
price of 16372-08-0
16372-08-0 Supplier
16372-08-0 Manufacturer
16372-08-0 Exporter
buy high quality Tofacitinib Impurity 33
Purchase Tofacitinib Impurity 33
Tofacitinib Impurity 33 suppliers
Tofacitinib Impurity 33 manufacturers
Tofacitinib Impurity 33 price
Order Tofacitinib Impurity 33
Enquire Tofacitinib Impurity 33
Tofacitinib Impurity 33 cost
Tofacitinib Impurity 33 Supplier
Tofacitinib Impurity 33 Distributor
Tofacitinib Impurity 33 for Method Validation
Tofacitinib Reference Standard
Tofacitinib Impurity 33 for ANDA Filing
Tofacitinib Impurity 33 for Forced Degradation Studies
Tofacitinib Impurity 33 Identification Standards
Tofacitinib Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.